Welcome to Shandong Sinobioway Biomedical Co., Ltd.
CN | EN

Home>About us > General

About Sinobioway

     Shandong Sinobioway Biomedical Co., Ltd.(hereinafter referred to as "Anonymous Pharmaceuticals" or "Company") is an A-share public company listed on the Shenzhen Stock Exchange which is under the control of an unnamed group. Stock Abbreviation: Unnamed Pharmaceutical, Stock Code: 002581 . On October 19, 2015, the company was renamed "Zibo Wanchang Science and Technology Co., Ltd.", a major asset reorganization. The company owns a subsidiary Biomedical Co., Ltd. (Xiamen), Tianjin unknown Biomedical Co., Ltd., Beijing Branch Hing Biological Products Co., Ltd., Shandong unknown Tianyuan Biological Technology Co., Ltd., Beijing unknown West Biological Technology Co., Ltd.,Peking University V-Ming (Hefei) Biologics Co., Ltd and other affiliated enterprises or production base.
      One of the three dreams of the unnamed group is to "solve the health problem in China": to establish a health product supply system through the development of the biopharmaceutical industry; to establish a health service system with Chinese characteristics through the development of modern Chinese medicine; to establish a life and health through the implementation of the GHP plan Management system. The unnamed medicine will focus on the development of three major systems of drug manufacturing, new drug research and development and product distribution to build a sound supply system for health products. By implementing the "one hundred petaflop project", the unnamed medicine will achieve the following goals by 2030: The unnamed medicine will account for the Chinese pharmaceutical market 10% of the total sales, accounting for 50% of the total sales of biopharmaceutical market, the market capitalization of listed companies (002581) more than one trillion; through the establishment of new drug highway, the unnamed medicine will receive 25 new drug certificate each year; through international companies Restructuring mergers and acquisitions, the unnamed medicine to become the world's largest pharmaceutical enterprise group.